News

Cathie Wood's Bold Stock Picks: DraftKings, Shopify, Tempus AI

Cathie Wood's Bold Stock Picks: DraftKings, Shopify, Tempus AI

Cathie Wood's Recent Stock Moves

Cathie Wood is actively adjusting Ark Invest's portfolio to navigate the current challenging market landscape. Many of the exchange-traded funds she manages are facing difficulties, even though the overall outlook for the year remains positive. Nevertheless, she maintains her confidence and is making substantial investments in innovative companies during this time. Wood frequently shares details about Ark's transactions, ensuring transparency in her investment decisions. This article highlights three significant acquisitions made by Wood recently: DraftKings (NASDAQ: DKNG), Shopify (NYSE: SHOP), and Tempus AI (NASDAQ: TEM).

DraftKings: Navigating a Competitive Betting Market

DraftKings has seen impressive growth, with its shares tripling in value last year. However, the stock is currently facing some challenges as growth slows and competition in the online sportsbook sector heats up. After achieving remarkable revenue growth rates exceeding 63% for four consecutive years, DraftKings reported only a 26% year-over-year increase in its most recent quarter.

The platform boasts a strong user base, with 8.4 million unique users over the past year—a 35% increase from the previous year. Additionally, the number of unique monthly payers has grown significantly, reaching 3.1 million in the latest quarter, which is a remarkable 50% rise compared to the same period last year. Despite these encouraging figures, revenue growth fell slightly short of expectations, partly due to a 15% drop in average revenue per unique payer compared to the previous year.

On a positive note, DraftKings surprised investors by reporting a profit, easing concerns following earlier earnings misses. Analysts are optimistic about the company's future, forecasting that DraftKings will achieve its first full-year profit by 2025.

In response to the competitive landscape, DraftKings is reinforcing its strategy with a $1 billion share buyback, demonstrating its confidence in future growth opportunities.

Shopify: A Strong Recovery in E-Commerce

Shopify is Ark Invest's largest holding, and Wood has recently increased her investment in this e-commerce giant. After facing difficulties earlier in the year, Shopify has made a strong comeback, reporting a 21% revenue increase to $2 billion in its latest quarter. When adjusting for the logistics segment it divested, revenue growth surged by 25%.

The company's primary merchant solutions segment experienced a 19% increase, complemented by an impressive 27% rise in its subscription solutions business, which now accounts for over a quarter of its total revenue. These positive developments have led to improved profit margins and a significant increase in free cash flow, further justifying Wood's substantial investment in Shopify.

Tempus AI: Pioneering Innovation in Healthcare

Tempus AI represents a new venture for Wood’s portfolio, being the only stock she purchased across multiple funds recently. After going public at $37 just two months ago, Tempus has shown positive stock performance following an encouraging quarterly report and strategic partnerships within the biotech sector.

Tempus is utilizing artificial intelligence (AI) to enhance healthcare, connecting with nearly two-thirds of academic medical centers and about half of oncologists nationwide. In its financial update, Tempus reported a 25% revenue increase to $166 million, significantly exceeding analyst expectations, while its adjusted losses were also reduced compared to earlier forecasts. Wood capitalized on a temporary dip in the stock price to increase her holdings in Tempus AI.

Should Investors Consider DraftKings?

Before investing in DraftKings, it's essential to carefully assess the company's market position and growth potential. DraftKings is a significant player in the expanding U.S. online betting market, which is expected to continue its upward trend.

Investors should balance the ongoing competitive challenges against DraftKings' strategy to strengthen its market presence while creating shareholder value through buybacks. As Ark Invest continues to back Wood's investment strategies, understanding her perspective on DraftKings and similar innovative companies will be vital.

Frequently Asked Questions

What companies did Cathie Wood recently invest in?

Cathie Wood recently increased her stakes in DraftKings, Shopify, and Tempus AI.

How has DraftKings performed in the market recently?

DraftKings shares saw significant growth last year but are currently facing challenges in a competitive environment, leading to a slowdown in revenue growth.

Why is Shopify significant in Cathie Wood's portfolio?

Shopify is Ark Invest's largest holding, demonstrating strong revenue growth and improved financial metrics, making it a crucial investment for Wood.

What is Tempus AI's focus in the industry?

Tempus AI focuses on utilizing artificial intelligence to enhance healthcare diagnostics and improve treatment outcomes.

What should investors look for in DraftKings?

Investors should evaluate the company's market strategy, growth potential, and financial health when considering an investment in DraftKings.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Vaccinex Unveils Efficacy Insights for Pepinemab in Alzheimer’s Study

Updated Category News Views 71

Vaccinex Provides Update on Pepinemab Study for Alzheimer’s Disease ROCHESTER, N.Y. — Vaccinex, Inc. (NASDAQ: VCNX), a forward-thinking biotechnology firm, is making significant strides in the treatment of Alzheimer's disease (AD) and cancer. The company is focused on a unique approach through the inhibition of Semaphorin 4D (SEMA4D). Recently, it was announced that...

Continue Reading
Legal Inquiry into Netflix, Inc. (NFLX) Attracts Investor Attention

Updated Category News Views 287

Understanding the Investigation into Netflix, Inc. Recently, the law firm Robbins Geller Rudman & Dowd LLP has initiated a formal investigation into Netflix, Inc. (NASDAQ: NFLX). This inquiry primarily focuses on potential violations of U.S. federal securities laws that may have occurred within the company. The Implications for Investors This investigation comes at a...

Continue Reading
Norway's Wealth Fund Expands Portfolio with London Investment

Updated Category News Views 221

Norway's Sovereign Wealth Fund Takes Bold Step in London Norway's sovereign wealth fund, expertly managed by Norges Bank Investment Management, has recently made headlines with its strategic acquisition of a 25% stake in a notable portfolio of office and retail properties located in London's prestigious Mayfair district. Significant Investment in a Prime Location This...

Continue Reading
Exagen Inc. Announces New Biomarkers and Financial Success

Updated Category News Views 291

Exagen Inc. Introduces Groundbreaking Biomarkers for Autoimmune Diseases Innovative testing aims to enhance patient diagnosis and care Exagen Inc. (Nasdaq: XGN), a pioneering company in autoimmune testing, has achieved a significant milestone by receiving conditional approval from the New York State Department of Health for its advanced assays to diagnose systemic lupus...

Continue Reading
Pacaso's Financial Growth in 2025: A Closer Look At Results

Updated Category News Views 1306

Pacaso Shows Promising First Half Financial Performance Pacaso, the innovative platform for co-owned luxury vacation homes, has recently shared its financial results for the first half of 2025, demonstrating strong stability and improved efficiency despite a challenging broader housing market. The company reported an impressive adjusted gross profit while managing to...

Continue Reading